Latest Breaking News On - Avik sengupta - Page 2 : comparemela.com

Business News | FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

Get latest articles and stories on Business at LatestLY. Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct Biologics is the first and only EV company to receive FDA Phase 3 approval for an Investigational New Drug (IND) indication to date. Business News | FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial.

South africaUnited statesMark adamsJoe schmidtAvik senguptaDirect biologicsAcute respiratory distress syndromeInvestigational new drugRegenerative medicine advanced therapyChief medical

New Landmark Trial for Phase 3 Acute Respiratory Distress Syndrome

Direct Biologics announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, | New Landmark Trial for Phase 3 Acute Respiratory Distress Syndrome

South africaUnited statesMark adamsJoe schmidtAvik senguptaDirect biologicsAcute respiratory distress syndromeInvestigational new drugRegenerative medicine advanced therapyChief medical

FDA approves Direct Biologics to proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

FDA approves Direct Biologics to proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
northernirelandnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from northernirelandnews.com Daily Mail and Mail on Sunday newspapers.

South africaUnited statesMark adamsJoe schmidtAvik senguptaRegenerative medicine advanced therapyDirect biologicsChief medical

FDA approves Direct Biologics to proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

FDA approves Direct Biologics to proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

South africaUnited statesMark adamsJoe schmidtAvik senguptaRegenerative medicine advanced therapyDirect biologicsChief medical

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

/PRNewswire/ Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today.

South africaUnited statesMark adamsJoe schmidtAvik senguptaAcute respiratory distress syndromeInvestigational new drugRegenerative medicine advanced therapyDirect biologicsChief medical